Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zetiq Technologies has developed and clinically validated its proprietary CellDetect® technology, which enables differential staining and morphological visualization to distinguish between non-cancerous and various types of cancer cells. Their first product—a kit for early detection of cervical cancer—demonstrated superior effectiveness and precision compared to existing tests. The company has also advanced products targeting bladder cancer diagnosis, with regulatory efforts underway in North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zetiq Technologies.